Bhaskar S Kolachana

Author PubWeight™ 67.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003 12.50
2 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005 10.13
3 Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004 5.70
4 Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003 5.11
5 The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004 4.84
6 A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 2005 4.33
7 The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009 3.03
8 Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry 2003 2.82
9 Effect of catechol-O-methyltransferase val158met genotype on attentional control. J Neurosci 2005 2.37
10 Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry 2006 1.94
11 Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 2003 1.82
12 Tolcapone improves cognition and cortical information processing in normal human subjects. Neuropsychopharmacology 2006 1.71
13 Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. J Clin Invest 2008 1.43
14 Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Biol Psychiatry 2007 1.41
15 Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk. Am J Psychiatry 2008 1.33
16 Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum Genet 2006 1.29
17 Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism. Mov Disord 2004 1.14
18 Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Biol Psychiatry 2004 1.14
19 Impact of interacting functional variants in COMT on regional gray matter volume in human brain. Neuroimage 2008 1.10
20 The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease. J Neurol 2005 1.09
21 Epistatic and functional interactions of catechol-o-methyltransferase (COMT) and AKT1 on neuregulin1-ErbB signaling in cell models. PLoS One 2010 0.88
22 Prefrontal electrophysiologic "noise" and catechol-O-methyltransferase genotype in schizophrenia. Biol Psychiatry 2006 0.87
23 Brain-derived neurotrophic factor Val⁶⁶Met polymorphism affects resting regional cerebral blood flow and functional connectivity differentially in women versus men. J Neurosci 2012 0.84